Explore the vast range of titles available.

Large-scale collection of data could help curb the COVID-19 pandemic, but it should not neglect privacy and public trust. Best practices should be identified to maintain responsible data-collection and data-processing standards at a global scale.

Recent studies raised concerns about the increasing use of gabapentinoids in different countries. With their potential for misuse and addiction, understanding the global consumption of gabapentinoids will offer us a platform to examine the need for any interventional policies. This longitudinal trend study utilised pharmaceutical sales data from 65 countries and regions across the world to evaluate the global trends in gabapentinoid consumption between 2008-2018. The multinational average annual percentage change of gabapentinoid consumption was +17.20%, increased from 4.17 defined daily dose per ten thousand inhabitants per day (DDD/TID) in 2008 to 18.26 DDD/TID in 2018. High-income countries had the highest pooled gabapentinoid consumption rate (39.92 DDD/TID) in 2018, which was more than six times higher than the lower-middle income countries (6.11 DDD/TID). The study shows that despite differences in healthcare system and culture, a consistent increase in gabapentinoid consumption is observed worldwide, with high-income countries remaining the largest consumers. With their misuse potential, there is a need to understand the global consumption of gabapentinoids. Here, authors show a + 17.20% worldwide average annual increase in consumption of gabapentinoids from 2008 to 2018.

This study aims to create predictive models for PA guidelines by using ML and examine the critical determinants influencing adherence to the PA guidelines. 11,638 entries from the National Health and Nutrition Examination Survey were analyzed. Variables were categorized into demographic, anthropometric, and lifestyle categories. 18 prediction models were created by 6 ML algorithms and evaluated via accuracy, F1 score, and area under the curve (AUC). Additionally, we employed permutation feature importance (PFI) to assess the variable significance in each model. The decision tree using all variables emerged as the most effective method in the prediction for PA guidelines (accuracy = 0.705, F1 score = 0.819, and AUC = 0.542). Based on the PFI, sedentary behavior, age, gender, and educational status were the most important variables. These results highlight the possibilities of using data-driven methods with ML in PA research. Our analysis also identified crucial variables, providing valuable insights for targeted interventions aimed at enhancing individuals’ adherence to PA guidelines.

Identifying the prevalence of degenerative spinal pathologies and relevant demographic risk factors is important for understanding spine injury risk, prevention, treatment, and outcome, and for distinguishing acute injuries from degenerative pathologies. Prevalence data in the literature are often based on small-scale studies focused on a single type of pathology. This study evaluates the prevalence of diagnosis of selected degenerative spinal pathology diagnoses using Medicare insurance claim data in the context of published smaller-scale studies. In addition, the data are used to evaluate whether the prevalence is affected by age, sex, diagnosed obesity, and the use of medical imaging. The Medicare Claims 5% Limited Data Set was queried to identify diagnoses of degenerative spinal pathologies. Unique patient diagnoses per year were further evaluated as a function of age, gender, and obesity diagnosis. Participants were also stratified by coding for radiological imaging accompanying each diagnosis. The overall prevalence of diagnosed spinal degenerative disease was 27.3% and increased with age. The prevalence of diagnosed disc disease was 2.7 times greater in those with radiology. The results demonstrate that degenerative findings in the spine are common, and, since asymptomatic individuals may not receive a diagnosis of degenerative conditions, this analysis likely underestimates the general prevalence of these conditions.

Three years after the start of the pandemic, SARS-CoV-2 shows no signs of settling into a seasonal pattern of spread, like influenza has. Three years after the start of the pandemic, SARS-CoV-2 shows no signs of settling into a seasonal pattern of spread, like influenza has. Credit: Narinder Nanu/AFP via Getty A health worker collects a nasal swab sample from a woman to test for the Covid-19 coronavirus at a hospital in Amritsar.

Prevalence of a new subvariant of Omicron is increasing, but whether it will cause a big surge in infections or hospitalizations isn’t clear. Prevalence of a new subvariant of Omicron is increasing, but whether it will cause a big surge in infections or hospitalizations isn’t clear. A healthcare professional wearing PPE administers a COVID-19 test to a patient in his car

Stroke is a significant cause of mortality and disability in India, with its economic impact on the rise. This study aims to investigate the prevalence and factors associated with stroke among the elderly population in seven north-eastern states of India and its economic consequences. Data from the initial phase of the Longitudinal Ageing Study in India (2017–2018) were utilized, and bivariate and multivariate analyses were done. Stroke prevalence (1.53%) was notable among both genders, with approximately 1% in females and 2.3% in males. Individuals with low physical activity, higher socio-economic status, and unemployment faced a higher risk of stroke. Females exhibited a 60% lower likelihood [AOR 0.40; (CI 0.250–0.627)] of stroke compared to males and hypertension was a significant risk factor. Stroke patients incur up to INR 50,000 of financial burden, with a considerable proportion facing disability in comprehension and speech. The economic burden of stroke-related hospitalization was significantly high, emphasizing the need for government-funded health insurance to cover stroke-related medications and reducing out-of-pocket expenses for patients seeking treatment in healthcare facilities. The study highlights the urgency for better schemes to address the growing threat of strokes in the north-eastern parts of India for comprehensively tackling this public health challenge.

Typing has become increasingly integral to everyday functioning. To comprehensively understand people’s level of functioning, researchers may also want to consider typing performance in addition to performance of other classical activities of daily living like dressing, shopping, or managing a budget. Classical typing tests are too burdensome to administer in panel studies. We examined functional and cognitive correlates of a one sentence typing speed test to examine if this brief measure could provide meaningful information. A sample of 10,613 adult participants in the Understanding America Study (UAS), a nationally representative longitudinal online survey panel, completed surveys, cognitive tests, and the typing test. Intraclass correlation coefficients of 0.79 for computer typing speed and 0.63 for smartphone typing speed suggested high test–retest stability for the brief typing test across 2 years. Faster typing speed was generally associated with better cognitive functioning across domains, fewer reported difficulties with basic and instrumental activities of daily living, and a lower likelihood of several self-reported illnesses. After adjustment for demographics, the correlation magnitudes were attenuated but still generally in the expected directions. Typing speed as captured by a single sentence typing speed test appeared to be sensitive to several measures relevant to everyday functioning.

Key Points Endocrine-disrupting chemicals (EDCs) might increase the risk of childhood neurodevelopmental disorders or obesity by disrupting hormone-mediated processes during critical periods of development The developing fetus, infant and child might have enhanced sensitivity to environmental stressors such as EDCs and increased exposure to some EDCs due to developmentally appropriate behaviour, anatomy and physiology The available epidemiological evidence suggest that prenatal bisphenol A and phthalate exposure is associated with adverse neurobehavioural outcomes in children, but not excess adiposity or risk of obesity or being overweight Epidemiological studies show that prenatal PFAS exposure is associated with reduced fetal growth, excess adiposity and risk of being overweight or obese, but not neurobehavioural outcomes Improving EDC exposure measurement, reducing confounding bias, identifying discrete periods of vulnerability and sexually dimorphic associations, and quantifying the effects of EDC mixtures will enhance inferences made from epidemiological studies Endocrine-disrupting chemicals (EDCs) can increase the risk of childhood diseases by disrupting hormone-mediated processes critical for growth and development. Here, Joseph Braun discusses epidemiological evidence of associations between early-life exposure to EDCs and childhood neurodevelopmental disorders and obesity. Endocrine-disrupting chemicals (EDCs) might increase the risk of childhood diseases by disrupting hormone-mediated processes that are critical for growth and development during gestation, infancy and childhood. The fetus, infant and child might have enhanced sensitivity to environmental stressors such as EDCs due to their rapid development and increased exposure to some EDCs as a consequence of development-specific behaviour, anatomy and physiology. In this Review, I discuss epidemiological studies examining the relationship between early-life exposure to bisphenol A (BPA), phthalates, triclosan and perfluoroalkyl substances (PFAS) with childhood neurobehavioural disorders and obesity. The available epidemiological evidence suggest that prenatal exposure to several of these ubiquitous EDCs is associated with adverse neurobehaviour (BPA and phthalates) and excess adiposity or increased risk of obesity and/or overweight (PFAS). Quantifying the effects of EDC mixtures, improving EDC exposure assessment, reducing bias from confounding, identifying periods of heightened vulnerability and elucidating the presence and nature of sexually dimorphic EDC effects would enable stronger inferences to be made from epidemiological studies than currently possible. Ultimately, improved estimates of the causal effects of EDC exposures on child health could help identify susceptible subpopulations and lead to public health interventions to reduce these exposures.

Researchers with the World Health Organization explain mistakes in high-profile mortality estimates for Germany and Sweden. Researchers with the World Health Organization explain mistakes in high-profile mortality estimates for Germany and Sweden.